Options Performance on $CRNX - By Diego Garcia del Rio
September 25, 2025 marked a turning point for Crinetics Pharmaceuticals ($CRNX). On that day, the FDA approved paltusotine (PALSONIFY™) as the first oral treatment for acromegaly, an event that immediately transformed the company's valuation of...
Spanish 
English 
German 
French